Login

Diversey IPO Preview with CEO Phil Wieland | Phil Wieland - CEO of Diversey Holdings 00:10:00

Share On Facebook Share On Twitter

Phil Wieland is the CEO of Diversey Holdings

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Matador Mining, an ASX Listed Company, explores for high-grade gold in Newfoundland, Canada.|Sam Pazuki is CEO/MD of Matador Mining
00:10:00
Revival Gold Expands High-Grade Resource at Beartrack-Arnett
00:10:00
Ireland's EU Journey and Identity Challenges|Mark Dooley,Professor,Boston College
00:10:00
Sfermion is NFT-focused fund with managing partners|Andrew Steinwold,Managing Partner,Sfermion
00:10:00
Franco Castelli edition | Counsel, Antitrust of Wachtell, Lipton, Rosen & Katz
00:10:00
"Dive into an exclusive interview with Mr. John Lai, CEO & President of PetVivo Holdings, Inc., as he shares groundbreaking developments and visionary strategies driving the company's success."|Mr. Lai has been a director and senior executive officer of P
00:10:00
Eastmain Resources Highlights High-Grade Gold Projects in Quebec at One-to-One London.
00:10:00
In the Canadian Business' Portraits in Leadership program, a reflection on leadership underscores the importance of relationships and understanding others' needs for mutual benefit and growth.|Jean-Louis Servranckx is President and Chief Executive Office
00:10:00
Shifting Market Dynamics: Evaluating Risk and Opportunity | Sébastien Page, CIO , T. Rowe Price.
00:10:00
Natasha Brook-Walters on Building Trust and Innovative Strategies at iStrat
00:10:00
Forge Chile Foundation - Building Key Skills for Your Future | LarrainVial Asset Management
00:10:00
Interview with Lori Kelley from Warren Averett Accounting

© 2017 - Neuhu+